As CEO of Korro Bio, Ram Aiyar leads the development of RNA editing therapies. An entrepreneur with a PhD from Drexel University, he co-founded Corvidia Therapeutics, which was acquired for $2. 1B. People who have worked with him describe him as a creative, collaborative, and thoughtful leader.
Ram is passionate about solving unmet medical needs by finding and developing disruptive technologies. He describes himself as a "deal junkie" constantly looking for the next commercially viable business plan. He also has a stated interest in motivating young people to pursue careers in science and technology.
He was instrumental in the $2. 1 billion acquisition of Corvidia Therapeutics by Novo Nordisk, a company he co-founded and served as its Chief Financial Officer.
Read the full overview →Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.
Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.